This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weigel-Kelley, K. A.
Right arrow Articles by Srivastava, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weigel-Kelley, K. A.
Right arrow Articles by Srivastava, A.

 Previous Article  |  Next Article 

Journal of Virology, May 2001, p. 4110-4116, Vol. 75, No. 9
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.9.4110-4116.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Recombinant Human Parvovirus B19 Vectors: Erythrocyte P Antigen Is Necessary but Not Sufficient for Successful Transduction of Human Hematopoietic Cells

Kirsten A. Weigel-Kelley,1,2 Mervin C. Yoder,3 and Arun Srivastava1,2,4,*

Department of Microbiology and Immunology,1 Walther Oncology Center,2 Herman B. Wells Center for Pediatric Research and Department of Biochemistry and Molecular Biology,3 and Division of Hematology/Oncology,4 Department of Medicine, Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, Indiana 46202-5120

Received 22 November 2000/Accepted 8 February 2001

The blood group P antigen, known to be abundantly expressed on erythroid cells, has been reported to be the cellular receptor for parvovirus B19. We have described the development of recombinant parvovirus B19 vectors with which high-efficiency, erythroid lineage-restricted transduction can be achieved (S. Ponnazhagan, K. A. Weigel, S. P. Raikwar, P. Mukherjee, M. C. Yoder, and A. Srivastava, J. Virol. 72:5224-5230, 1998). However, since a low-level transduction of nonerythroid cells could also be detected and since P antigen is expressed in nonerythroid cells, we reevaluated the role of P antigen in the viral binding and entry into cells. Cell surface expression analyses revealed that ~75% of primary human bone marrow mononuclear erythroid cells and ~31% of cells in the nonerythroid population were positive for P antigen. Two human erythroleukemia cell lines, HEL and K562, and a human promyelocytic leukemia cell line, HL-60, were also examined for P antigen expression and binding and entry of the vector. HEL and K562 cells showed intermediate levels, whereas HL-60 cells demonstrated high levels of expression of P antigen. However, the efficiency of vector binding to these cells did not correlate with P antigen expression. Moreover, despite P antigen positivity and efficient viral binding, HEL, K562, and HL-60 cells could not be transduced with the vector. Low levels of P antigen expression could also be detected in two primary cell types, human umbilical vein endothelial cells (HUVEC) and normal human lung fibroblasts (NHLF). In addition, vector binding occurred in both cell types and was inhibited by globoside, indicating the involvement of P antigen in virus binding to these cells. These primary cells could be efficiently transduced with the recombinant vector. These data suggest that (i) P antigen is expressed on a variety of cell types and is involved in binding of parvovirus B19 to human cells, (ii) the level of P antigen expression does not correlate with the efficiency of viral binding, (iii) P antigen is necessary but not sufficient for parvovirus B19 entry into cells, and (iv) parvovirus B19 vectors can be used to transduce HUVEC and NHLF. These studies further suggest the existence of a putative cellular coreceptor for efficient entry of parvovirus B19 into human cells.

* Corresponding author. Mailing address: Department of Microbiology and Immunology, 635 Barnhill Dr., Medical Science Building, Room 247, Indiana University School of Medicine, Indianapolis, IN 46202-5120. Phone: (317) 274-2194. Fax: (317) 274-4090. E-mail: asrivast{at}iupui.edu.

Journal of Virology, May 2001, p. 4110-4116, Vol. 75, No. 9
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.9.4110-4116.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Bonsch, C., Kempf, C., Ros, C. (2008). Interaction of Parvovirus B19 with Human Erythrocytes Alters Virus Structure and Cell Membrane Integrity. J. Virol. 82: 11784-11791 [Abstract] [Full Text]  
  • Wong, S., Zhi, N., Filippone, C., Keyvanfar, K., Kajigaya, S., Brown, K. E., Young, N. S. (2008). Ex Vivo-Generated CD36+ Erythroid Progenitors Are Highly Permissive to Human Parvovirus B19 Replication. J. Virol. 82: 2470-2476 [Abstract] [Full Text]  
  • Waldman, M., Kopp, J. B. (2007). Parvovirus B19 and the Kidney. CJASN 2: S47-S56 [Abstract] [Full Text]  
  • Schmidt, M., Chiorini, J. A. (2006). Gangliosides are essential for bovine adeno-associated virus entry.. J. Virol. 80: 5516-5522 [Abstract] [Full Text]  
  • Fujii, Y., Numata, S.-i., Nakamura, Y., Honda, T., Furukawa, K., Urano, T., Wiels, J., Uchikawa, M., Ozaki, N., Matsuo, S.-i., Sugiura, Y., Furukawa, K. (2005). Murine glycosyltransferases responsible for the expression of globo-series glycolipids: cDNA structures, mRNA expression, and distribution of their products. Glycobiology 15: 1257-1267 [Abstract] [Full Text]  
  • Munakata, Y., Saito-Ito, T., Kumura-Ishii, K., Huang, J., Kodera, T., Ishii, T., Hirabayashi, Y., Koyanagi, Y., Sasaki, T. (2005). Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 106: 3449-3456 [Abstract] [Full Text]  
  • Kaufmann, B., Simpson, A. A., Rossmann, M. G. (2004). The structure of human parvovirus B19. Proc. Natl. Acad. Sci. USA 101: 11628-11633 [Abstract] [Full Text]  
  • Vihinen-Ranta, M., Suikkanen, S., Parrish, C. R. (2004). Pathways of Cell Infection by Parvoviruses and Adeno-Associated Viruses. J. Virol. 78: 6709-6714 [Full Text]  
  • Corcoran, A., Doyle, S. (2004). Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 53: 459-475 [Abstract] [Full Text]  
  • Weigel-Kelley, K. A., Yoder, M. C., Srivastava, A. (2003). {alpha}5{beta}1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of {beta}1 integrin for viral entry. Blood 102: 3927-3933 [Abstract] [Full Text]  
  • Tolfvenstam, T., Papadogiannakis, N., Andersen, A., Akre, O. (2002). No association between human parvovirus B19 and testicular germ cell cancer. J. Gen. Virol. 83: 2321-2324 [Abstract] [Full Text]  
  • Heegaard, E. D., Brown, K. E. (2002). Human Parvovirus B19. Clin. Microbiol. Rev. 15: 485-505 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»